Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
75,651,199
-
Shares change
-
+5,518,717
-
Total reported value, excl. options
-
$530,307,280
-
Value change
-
+$37,811,777
-
Put/Call ratio
-
56%
-
Number of buys
-
80
-
Number of sells
-
89
-
Price
-
$7.01
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2022
As of 30 Jun 2022 CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) had 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 75,651,199 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, LSV ASSET MANAGEMENT, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, GOLDMAN SACHS GROUP INC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 211 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.